Motif Bio Plc Total Long-Term Assets 2015-2020 | MTFB

Motif Bio Plc total long-term assets from 2015 to 2020. Total long-term assets can be defined as the sum of all assets classified as non-current

Motif Bio Plc Total Long-Term Assets 2015-2020 | MTFB

Motif Bio Plc total long-term assets from 2015 to 2020. Total long-term assets can be defined as the sum of all assets classified as non-current
Related Stocks
Company NameMarket
Cap
Vertex Pharmaceuticals Incorporated (VRTX)$133.1B
Regeneron Pharmaceuticals, Inc. (REGN)$91B
Vaxcyte, Inc. (PCVX)$13.3B
Bio-Techne Corp (TECH)$12.1B
Revolution Medicines, Inc. (RVMD)$10.2B
QIAGEN N.V. (QGEN)$10B
Repligen Corporation (RGEN)$7.9B
Viking Therapeutics, Inc. (VKTX)$7.6B
Nuvalent, Inc. (NUVL)$6.2B
Avidity Biosciences, Inc. (RNA)$5.1B
Ultragenyx Pharmaceutical Inc. (RARE)$4.7B
Rhythm Pharmaceuticals, Inc. (RYTM)$4.1B
ImmunityBio, Inc. (IBRX)$3.9B
Xenon Pharmaceuticals Inc. (XENE)$3.4B
Verona Pharma PLC American Depositary Share (VRNA)$3.1B
Zai Lab Limited Unsponsored ADR (ZLAB)$3.1B
Protagonist Therapeutics, Inc. (PTGX)$2.7B
Twist Bioscience Corporation (TWST)$2.7B
Vera Therapeutics, Inc. (VERA)$2.6B
SpringWorks Therapeutics (SWTX)$2.5B
Scholar Rock Holding Corporation (SRRK)$2.3B
Neumora Therapeutics, Inc. (NMRA)$2.2B
WAVE Life Sciences Ltd. (WVE)$2.1B
NeoGenomics, Inc. (NEO)$2B
Nurix Therapeutics, Inc. (NRIX)$1.9B
NovoCure Limited (NVCR)$1.9B
Tarsus Pharmaceuticals, Inc. (TARS)$1.9B
Syndax Pharmaceuticals, Inc. (SNDX)$1.9B
Celldex Therapeutics, Inc. (CLDX)$1.7B
Intellia Therapeutics, Inc. (NTLA)$1.7B